# Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15, 1068

**Authors:** Hoda Awad, Basmala Hassan, Sara Dweek, Yasmeen Aboelata, Mutasem Rawas-Qalaji, Iman Saad Ahmed

PMC · DOI: 10.3390/ph17081100 · Pharmaceuticals · 2024-08-22

## Full-text entities

- **Diseases:** COVID-19 (MESH:D000086382)
- **Chemicals:** Ivermectin (MESH:D007559)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11360210/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC11360210/full.md

---
Source: https://tomesphere.com/paper/PMC11360210